Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
Authors:
Open Access
- 15 April 2025
- journal article
- review article
- Published by Elsevier in Journal of Proteomics
- Vol. 316, 105442
Abstract
No abstract availableKeywords
Funding Information
- Crafoordska Stiftelsen (20240554)
- Austrian Science Fund (I3522)
- Austrian Science Fund (I4677)
- Austrian Science Fund (I3977)
- HORIZON EUROPE Marie Sklodowska-Curie Actions (HORIZON-MSCA-2022-SE-01)
- Semmelweis Egyetem
- International Association for the Study of Lung Cancer
- European Commission
- National Cancer Institute
- Fru Berta Kamprads Stiftelse
- National Research Foundation of Korea
- Magyar Tudományos Akadémia
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (FK-143751)
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (TKP2021-EGA-33)
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (FK-147045)
This publication has 31 references indexed in Scilit:
- Mitochondrial dysfunction and immune suppression in BRAF V600E‐mutated metastatic melanomaClinical and Translational Medicine, 2024
- Mitochondrial and immune response dysregulation in melanoma recurrenceClinical and Translational Medicine, 2023
- In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancerClinical and Translational Medicine, 2022
- Processing and Cryopreservation of Blood, Cancer Tissues, and Cancer Cells for Viable Biobanking2022
- High-throughput proteomics and AI for cancer biomarker discoveryAdvanced Drug Delivery Reviews, 2021
- A biobanking turning‐point in the use of formalin‐fixed, paraffin tumor blocks to unveil kinase signaling in melanomaClinical and Translational Medicine, 2021
- Basic principles of biobanking: from biological samples to precision medicine for patientsVirchows Archiv, 2021
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAAnnals of Oncology, 2020
- Clinical protein science in translational medicine targeting malignant melanomaCell Biology and Toxicology, 2019
- The Case for Proteomics and Phospho‐Proteomics in Personalized Cancer MedicineProteomics – Clinical Applications, 2019